Annual ROE
-49.88%
-5.87%-13.34%
December 31, 2023
Summary
- As of February 22, 2025, ACRS annual return on equity is -49.88%, with the most recent change of -5.87% (-13.34%) on December 31, 2023.
- During the last 3 years, ACRS annual ROE has risen by +44.98% (+47.42%).
- ACRS annual ROE is now -187.29% below its all-time high of 57.14%, reached on December 31, 2013.
Performance
ACRS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-25.72%
+12.43%+32.58%
September 30, 2024
Summary
- As of February 22, 2025, ACRS quarterly return on equity is -25.72%, with the most recent change of +12.43% (+32.58%) on September 30, 2024.
- Over the past year, ACRS quarterly ROE has increased by +35.88% (+58.25%).
- ACRS quarterly ROE is now -112.23% below its all-time high of 210.28%, reached on June 30, 2015.
Performance
ACRS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ACRS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.3% | +58.3% |
| 3 y3 years | +47.4% | +59.4% |
| 5 y5 years | +17.3% | +78.3% |
ACRS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.3% | +35.5% | at high | +58.3% |
| 5 y | 5-year | -13.3% | +55.9% | at high | +80.3% |
| alltime | all time | -187.3% | +55.9% | -112.2% | +80.3% |
Aclaris Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -25.72%(-32.6%) |
| Jun 2024 | - | -38.15%(-19.8%) |
| Mar 2024 | - | -47.57%(-6.7%) |
| Dec 2023 | -49.88%(+13.3%) | -50.99%(-17.2%) |
| Sep 2023 | - | -61.60%(+18.1%) |
| Jun 2023 | - | -52.15%(+9.4%) |
| Mar 2023 | - | -47.65%(+13.0%) |
| Dec 2022 | -44.01%(-43.1%) | -42.16%(+7.8%) |
| Sep 2022 | - | -39.10%(-0.1%) |
| Jun 2022 | - | -39.14%(-9.0%) |
| Mar 2022 | - | -43.02%(-24.5%) |
| Dec 2021 | -77.33%(-18.5%) | -56.96%(-10.1%) |
| Sep 2021 | - | -63.36%(-15.1%) |
| Jun 2021 | - | -74.65%(-30.6%) |
| Mar 2021 | - | -107.60%(+7.9%) |
| Dec 2020 | -94.86%(-16.2%) | -99.69%(+7.2%) |
| Sep 2020 | - | -92.98%(-26.4%) |
| Jun 2020 | - | -126.38%(-3.4%) |
| Mar 2020 | - | -130.78%(+11.8%) |
| Dec 2019 | -113.22% | -116.96%(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -118.32%(+27.5%) |
| Jun 2019 | - | -92.81%(+21.7%) |
| Mar 2019 | - | -76.26%(+10.5%) |
| Dec 2018 | -60.28%(+73.6%) | -69.03%(+16.8%) |
| Sep 2018 | - | -59.12%(+16.7%) |
| Jun 2018 | - | -50.66%(+23.1%) |
| Mar 2018 | - | -41.14%(+19.8%) |
| Dec 2017 | -34.72%(+22.4%) | -34.35%(+11.7%) |
| Sep 2017 | - | -30.75%(-10.2%) |
| Jun 2017 | - | -34.24%(-9.9%) |
| Mar 2017 | - | -37.99%(-16.2%) |
| Dec 2016 | -28.37%(+27.6%) | -45.35%(-4.8%) |
| Sep 2016 | - | -47.62%(-34.3%) |
| Jun 2016 | - | -72.43%(-13.3%) |
| Mar 2016 | - | -83.50%(-11.8%) |
| Dec 2015 | -22.23%(-154.2%) | -94.62%(-182.2%) |
| Sep 2015 | - | 115.10%(-45.3%) |
| Jun 2015 | - | 210.28%(+454.1%) |
| Mar 2015 | - | 37.95%(+49.9%) |
| Dec 2014 | 41.04%(-28.2%) | 25.31% |
| Dec 2013 | 57.14% | - |
FAQ
- What is Aclaris Therapeutics annual return on equity?
- What is the all time high annual ROE for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual ROE year-on-year change?
- What is Aclaris Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly ROE year-on-year change?
What is Aclaris Therapeutics annual return on equity?
The current annual ROE of ACRS is -49.88%
What is the all time high annual ROE for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual return on equity is 57.14%
What is Aclaris Therapeutics annual ROE year-on-year change?
Over the past year, ACRS annual return on equity has changed by -5.87% (-13.34%)
What is Aclaris Therapeutics quarterly return on equity?
The current quarterly ROE of ACRS is -25.72%
What is the all time high quarterly ROE for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly return on equity is 210.28%
What is Aclaris Therapeutics quarterly ROE year-on-year change?
Over the past year, ACRS quarterly return on equity has changed by +35.88% (+58.25%)